PedAM
Pediatric Disease Annotations & Medicines
| Disease | neuroendocrine tumor |
| Phenotype | C0024586|carcinoid syndrome |
| Sentences | 7 |
| PubMedID- 21279821 | Functional tumors are commonly associated with a specific hormonal syndrome directly related to a hormone secreted by the tumor, like gastrinomas with a zollinger-ellison syndrome or carcinoid syndrome in patients with neuroendocrine tumors (net) of the ileum. |
| PubMedID- 24144293 | neuroendocrine tumors presenting with the carcinoid syndrome and their cardiovascular manifestations are also discussed. |
| PubMedID- 26431405 | Placebo (pbo) for carcinoid syndrome (cs) in patients with neuroendocrine tumors (nets): subgroup analysis of the elect study. |
| PubMedID- 24403259 | The targeted cancers were hormone-receptor-positive advanced breast cancer, advanced neuroendocrine tumors associated with carcinoid syndrome, advanced renal cell carcinoma, and advanced pancreatic neuroendocrine tumor. |
| PubMedID- 26315553 | Background: octreotide long-acting repeatable (lar) is approved in the united states for the management of carcinoid syndromes among patients with neuroendocrine tumors (net). |
| PubMedID- 25824001 | Background/aims: the phase iii placebo-controlled radiant-2 trial investigated the efficacy of everolimus plus octreotide long-acting repeatable (lar) in patients with advanced neuroendocrine tumors (net) associated with carcinoid syndrome. |
| PubMedID- 24833836 | [4] 50% of testicular neuroendocrine tumor with carcinoid syndrome metastasized and the larger tumor the higher risk for metastasis. |
Page: 1